Viridian Therapeutics, Inc.\DE (VRDN) Prepaid Assets (2013 - 2026)

Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Prepaid Assets came in at $22.6 million in Q1 2026, up 9.5% year-on-year from $20.6 million in Q1 2025, and up 15.23% quarter-over-quarter from $19.6 million in Q4 2025.

Viridian Therapeutics, Inc.\DE (VRDN) Prepaid Assets (2013 - 2026) Analysis & Trends

Viridian Therapeutics, Inc.\DE's Prepaid Assets history runs 14 years deep, the most recent figure standing at $22.6 million for Q1 2026.

  • On a quarterly basis, Prepaid Assets rose 9.5% year-over-year to $22.6 million in Q1 2026; TTM through Mar 2026 was $22.6 million, a 9.5% increase from a year earlier, with the FY2025 full-year figure at $19.6 million, down 6.21% from the prior year.
  • Prepaid Assets grew to $22.6 million in Q1 2026 per VRDN's latest filing, from $19.6 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $22.6 million in Q1 2026 and bottomed at $3.4 million in Q1 2022.
  • The 5-year median for Prepaid Assets is $11.0 million (2025), against an average of $12.2 million.
  • Across the five-year window, Prepaid Assets soared 180.83% in 2023 and slipped 21.92% in 2025, its largest moves.
  • Year by year, Prepaid Assets stood at $6.5 million in 2022, then jumped by 38.11% to $9.0 million in 2023, then soared by 131.81% to $20.9 million in 2024, then fell by 6.21% to $19.6 million in 2025, then increased by 15.23% to $22.6 million in 2026.
  • Per Business Quant, the three latest VRDN Prepaid Assets figures stand at $22.6 million (Q1 2026), $19.6 million (Q4 2025), and $11.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Viridian Therapeutics, Inc.\DE 229.55 Mn 229.55 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 22.56 Mn
Dec 31, 2025 19.58 Mn
Sep 30, 2025 11.01 Mn
Jun 30, 2025 15.39 Mn
Mar 31, 2025 20.61 Mn
Dec 31, 2024 20.88 Mn
Sep 30, 2024 14.10 Mn
Jun 30, 2024 10.30 Mn
Mar 31, 2024 13.53 Mn
Dec 31, 2023 9.01 Mn
Sep 30, 2023 10.73 Mn
Jun 30, 2023 11.94 Mn
Mar 31, 2023 8.62 Mn
Dec 31, 2022 6.52 Mn
Sep 30, 2022 5.64 Mn
Jun 30, 2022 4.25 Mn
Mar 31, 2022 3.44 Mn
Dec 31, 2021 2.75 Mn
Sep 30, 2021 3.65 Mn
Jun 30, 2021 4.11 Mn